Latest / Eyewire News: The Podcast

Weekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap • Lensar Receives European Approval for ALLY System • Lenz Therapeutics Submits NDA for Presbyopia Eye Drop
Learn more about your ad choices. Visit megaphone.fm/adchoices
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.